Gen Comp Endocrinol 174:97106 Shimizu M, Suzuki S, Horikoshi M, Hara A, Dickhoff WW (2011b) Circulating salmon 41-kDa insulin-like growth factor binding protein (IGFBP) is not IGFBP-3 but an IGFBP-2 subtype
The chelating agent may be administered intravenously, intramuscularly, or orally, depending on the agent and the type of poisoning
We typically start with a lower dosage and increase it gradually to minimize potential side effects
RSPO2 enhances canonical Wnt signaling to confer stemness-associated traits to susceptible pancreatic cancer cells
In addition, L-carnitine caused higher glycogen deposition in the fasting state, and increased and decreased the mRNA expressions of gluconeogenesis-related and glycolysis-related genes, respectively